ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO680

Establishment of a High-Throughput Screening System for Membrane Expression of Mutant Nephrin

Session Information

  • Pediatric Nephrology - 1
    October 25, 2024 | Location: Exhibit Hall, Convention Center
    Abstract Time: 10:00 AM - 12:00 PM

Category: Pediatric Nephrology

  • 1900 Pediatric Nephrology

Authors

  • Tsuhako, Haruki, Kumamoto Daigaku, Kumamoto, Kumamoto, Japan
  • Suico, Mary Ann, Kumamoto Daigaku, Kumamoto, Kumamoto, Japan
  • Shuto, Tsuyoshi, Kumamoto Daigaku, Kumamoto, Kumamoto, Japan
  • Kai, Hirofumi, Kumamoto Daigaku, Kumamoto, Kumamoto, Japan
Background

Congenital Nephrotic syndrome of the Finnish type (CNF) is caused by a mutation in the NPHS1 gene that hinders the cell surface expression of nephrin and disrupts slit membrane formation. In this study, we constructed a novel evaluation system to search for compounds promoting the expression of nephrin on the cell membrane.

Methods

To detect the membrane-expressed nephrin, we used the HiBiT nanoluciferase system by tagging Nephrin wild-type (wt) and mutants (mt) with HiBiT. For high throughput screening (HTS), we generated stable expression cell lines of HiBiT- wt and mutant nephrin (HiBiT-Neph) using the Flp-InTM System. Phosphorylated-Nephrin, which indicates the ability to be translocated to the surface, was also assessed by immunoblotting.

Results

In contrast to wt HiBiT-Neph, most mutants did not produce luminescence and were not phosphorylated. Furthermore, among the mutants, we confirmed that the reduction of HiBiT activity in the S366R and E725D stable mutant cells met the HTS criteria. Using E725D stable cells, we screened several chemical chaperones and a natural products compound library. Chemical chaperone β-alanine, a CFTR corrector (Corr-4a), and 78 compounds from the library increased the HiBiT-Neph E725D. Cytotoxicity assays and further validation by immunoblotting of phosphorylated nephrin trimmed the candidate compounds to ten. Focusing on these compounds, we revealed their effects on post-translational modifications and degradation rates of Nephrin to promote the expression of nephrin mutants on the membrane.

Conclusion

The HTS evaluation system identified compounds that increased mutant nephrin phosphorylation and cell surface expression and showed that this evaluation system is useful as a drug discovery platform for CNF. Moreover, the identified compounds help to elucidate the mechanisms of mutant nephrin cell regulation.